Sales & Earnings Roundup: Herbalife, MusclePharm, USANA
This article was originally published in The Tan Sheet
Executive Summary
Herbalife expects FTC settlement; currency exchange slams Mannatech; USANA overcomes currency impact; and more news in brief.
You may also be interested in...
ProPhase Tries Direct-Response Supplement Sales As Remedy For Seasonal Slumps
The marketer of the Cold-EEZE cold remedy line enters the supplement market with LegendzXL "to offset the seasonality of our revenues and our dependence on the severity of the cold season." The supplement contains a proprietary formulation for "supporting physical readiness, energy and relieving stress."
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.